Skip to main content

Call for papers - Advances in acute kidney injury

Guest Editor

Jakob Gubenšek, PhD, MD, University Medical Center Ljubljana, Slovenia

Submission Status: Open   |   Submission Deadline: 3 January 2025

BMC Nephrology is calling for submissions to our Collection, Advances in acute kidney injury. For this Collection, BMC Nephrology is looking for contributions that discuss the latest insights, innovations, and technological advancements, with a focus on biomarkers for early detection, public awareness and policy implications, innovative therapeutic approaches, renal replacement therapy, and risk factors and prevention strategies. 


New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

Meet the Guest Editor

Back to top

Jakob Gubenšek, PhD, MD, University Medical Center Ljubljana, Slovenia

Dr Jakob Gubenšek graduated from the University of Ljubljana Medical School, where he also completed his PhD thesis on "Regional citrate anticoagulation during hemodialysis", and finished his residency in Internal Medicine and Nephrology. Currently, Dr Gubenšek is Associate Professor at the Faculty of Medicine, University of Ljubljana and Head of the Center for Acute and Complicated Dialysis and Vascular Access in the Department of Nephrology, University Medical Center Ljubljana, Slovenia. He is involved in clinical work and research mainly in the fields of acute and chronic hemodialysis, apheresis, interventional nephrology, ultrasonography and vascular access surgery. Dr Gubenšek is a member of ERA, ISN, the Vascular Access Society, and the International Society for Apheresis.

About the Collection

BMC Nephrology is calling for submissions to our Collection, Advances in acute kidney injury. 

Acute kidney injury (AKI) is a globally significant health challenge, associated with heightened morbidity, mortality, and healthcare costs. Recent developments in AKI research have provided improved diagnostic strategies, novel biomarkers, and treatment strategies, reducing AKI-related and long-term complications. AKI progression into chronic kidney disease remains a significant issue requiring treatment strategies, reducing long-term complications and ensuring improved quality of life for patients. Addressing global health disparities and contributing to educational advancements, academic researchers play a crucial role in shaping the future of AKI management and prevention, establishing a collaborative, multidisciplinary approach across scientific disciplines and healthcare domains.

BMC Nephrology encourages submissions from researchers and experts working at the intersection of nephrology, urgent care, and healthcare policy. Additionally, those with expertise in genetics, molecular biology, biomarker discovery, and technology-driven innovations in AKI are welcome to contribute.

Contributions can include, but are not limited to, the following:

  • Novel biomarkers in AKI 
  • Public awareness campaigns on AKI: strategies and impact
  • Advances in renal replacement therapy modalities
  • Policy implications in AKI: bridging gaps for better outcomes
  • Exploring health equity in AKI incidence and care
  • Preventive measures and strategies for AKI
  • Risk factors: identification and analysis 
  • Novel therapeutic strategies for AKI management
  • Technological innovations shaping AKI research and practice


This collection supports and amplifies research related to SDG 3: Good Health and Well-Being, which seeks to ensure health and well-being for all, by contributing to the overall goal of promoting good health and well-being by reducing the impact of a significant health condition, improving healthcare outcomes, and enhancing the quality of life for individuals affected by kidney injury.


Image credit: peakSTOCK / Getty Images / iStock (Symbolbild mit Fotomodell)

  1. Sunitinib, a multi-targeted tyrosine kinase inhibitor, is used as a second-line therapy for gastrointestinal stromal tumors (GIST) resistant to imatinib. However, its impact on the vascular endothelial growth ...

    Authors: Xin Zhang, Hui Wang, Jian Li, Fude Zhou, Minghui Zhao and Tao Su
    Citation: BMC Nephrology 2024 25:284
    Content type: Case Report Published on:

  2. The mortality rate and prognosis of short-term and long-term acute kidney injury (AKI) patients who undergo continuous renal replacement therapy (CRRT) are different. Setting up risk stratification tools for b...

    Authors: Menglei Gu, Yalan Liu, Hongbin Sun, Haitong Sun, Yufei Fang, Luping Chen and Lu Zhang
    Citation: BMC Nephrology 2024 25:245
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Advances in acute kidney injury" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.